Patient selection for palliative chemotherapy among all patients with palliative treatment intent
| Patients (%) with palliative treatment intent | Patients (%) undergoing palliative chemotherapy | ||
|---|---|---|---|
| All patients | n=9768 | n=2313 | 23.7 |
| Age | |||
| Under 55 | 670 (6.9) | 344 | 51.3 |
| 55–64 | 1344 (13.8) | 626 | 46.6 |
| 65–74 | 2437 (24.9) | 853 | 35.0 |
| 75 and over | 5317 (54.4) | 490 | 9.2 |
| Gender | |||
| Female | 3429 (35.1) | 596 | 17.4 |
| Male | 6339 (64.9) | 1717 | 27.1 |
| Index of multiple deprivation | |||
| 1 (least) | 1806 (18.5) | 502 | 27.8 |
| 2 | 1832 (18.8) | 471 | 25.7 |
| 3 | 2016 (20.6) | 490 | 24.3 |
| 4 | 1967 (20.1) | 400 | 20.3 |
| 5 (most) | 2147 (22.0) | 450 | 21.0 |
| Tumour | |||
| Oesophagus | 5686 (58.2) | 1286 | 22.6 |
| Stomach | 4082 (41.8) | 1027 | 25.2 |
| Diagnosis (histology) | |||
| Adenocarcinoma | 7411 (75.9) | 1884 | 25.4 |
| Squamous cell | 1661 (17.0) | 304 | 18.3 |
| Other | 696 ( 7.1) | 125 | 18.0 |
| Pretreatment stage | |||
| 1 or 2 | 892 ( 9.1) | 83 | 9.3 |
| 3 | 1127 (11.5) | 239 | 21.2 |
| 4 | 3896 (39.9) | 1377 | 35.3 |
| Missing | 3853 (39.5) | 614 | 15.9 |
| ECOG/WHO performance status | |||
| 0 no restrictions | 1413 (14.5) | 622 | 44.0 |
| 1 restricted in strenuous activities | 1835 (18.8) | 620 | 33.8 |
| 2 unable to work or worse | 3474 (35.6) | 326 | 9.4 |
| Missing | 3046 (31.2) | 745 | 24.5 |
| Comorbidities | |||
| None | 5317 (54.4) | 1551 | 29.2 |
| 1 | 2638 (27.0) | 542 | 20.5 |
| 2 or more | 1813 (18.6) | 220 | 12.1 |
ECOG, Eastern Cooperative Oncology Group.